<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77558</article-id><article-id pub-id-type="doi">10.7554/eLife.77558</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A-type FHFs mediate resurgent currents through TTX-resistant voltage-gated sodium channels</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-271970"><name><surname>Xiao</surname><given-names>Yucheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271972"><name><surname>Theile</surname><given-names>Jonathan W</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-271969"><name><surname>Zybura</surname><given-names>Agnes</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272196"><name><surname>Pan</surname><given-names>Yanling</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271973"><name><surname>Lin</surname><given-names>Zhixin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-74448"><name><surname>Cummins</surname><given-names>Theodore R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9509-6380</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Biology Department</institution>, <institution>Indiana University - Purdue University Indianapolis</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Icagen, LLC</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Paul and Carole Stark Neurosciences Research Institute</institution>, <institution>Indiana University</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5115"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>yuchxiao@indiana.edu</email> (YX);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>trcummin@iu.edu</email> (TC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>04</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e77558</elocation-id><history><date date-type="received"><day>03</day><month>02</month><year>2022</year></date><date date-type="accepted"><day>19</day><month>04</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Xiao et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Xiao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77558-v1.pdf"/><abstract><p>Resurgent currents (<italic>I</italic><sub>NaR</sub>) produced by voltage-gated sodium channels are required for many neurons to maintain high-frequency firing, and contribute to neuronal hyperexcitability and disease pathophysiology. Here we show, for the first time, that <italic>I</italic><sub>NaR</sub> can be reconstituted in a heterologous system by co-expression of sodium channel α-subunits and A-type fibroblast growth factor homologous factors (FHFs). Specifically, A-type FHFs induces <italic>I</italic><sub>NaR</sub> from Nav1.8, Nav1.9 tetrodotoxin-resistant neuronal channels and, to a lesser extent, neuronal Nav1.7 and cardiac Nav1.5 channels. Moreover, we identified the N-terminus of FHF as the critical molecule responsible for A-type FHFs-mediated <italic>I</italic><sub>NaR</sub>. Among the FHFs, FHF4A is the most important isoform for mediating Nav1.8 and Nav1.9 <italic>I</italic><sub>NaR</sub>. In nociceptive sensory neurons, FHF4A knockdown significantly reduces <italic>I</italic><sub>NaR</sub> amplitude and the percentage of neurons that generate <italic>I</italic><sub>NaR</sub>, substantially suppressing excitability. Thus, our work reveals a novel molecular mechanism underlying TTX-resistant <italic>I</italic><sub>NaR</sub> generation and provides important potential targets for pain treatment.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS109896</award-id><principal-award-recipient><name><surname>Xiao</surname><given-names>Yucheng</given-names></name><name><surname>Cummins</surname><given-names>Theodore R</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS053422</award-id><principal-award-recipient><name><surname>Cummins</surname><given-names>Theodore R</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006977</institution-id><institution>Indiana State Department of Health</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Xiao</surname><given-names>Yucheng</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jonathan W Theile, is affiliated with Icagen, LLC. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf3"><p>Zhixin Lin, is affiliated with Icagen, LLC. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#SC307R) of the Indiana University - Purdue University Indianapolis.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript.</p></sec><supplementary-material><ext-link xlink:href="elife-77558-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>